Canine leishmaniosis and kidney disease: Q&A for an overall management in clinical practice

Roura, X., Cortadellas, O., Day, M.J., Benali, S.L., D'Anna, N., Fondati, A., Gradoni, L., Lubas, G., Maroli, M., Paltrinieri, S., Zini, E. and Zatelli, A. (2020) Canine leishmaniosis and kidney disease: Q&A for an overall management in clinical practice. Journal of Small Animal Practice . Early View.

Abstract

Canine leishmaniosis (CanL) is a systemic zoonotic disease caused by the protozoan Leishmania infantum (Paltrinieri et al. 2010), i.e. endemic in more than 70 countries (Solano‐Gallego et al. 2011). There is evidence of spread to traditionally non‐endemic areas such as North America (Gaskin et al. 2002, Duprey et al. 2006) and, especially, northern European countries such as the UK (Teske et al. 2002, Shaw et al. 2009, Geisweid et al. 2012, Maia & Cardoso 2015, Silvestrini et al. 2016, Medlock et al. 2018). Increases in the number of CanL cases in the UK might well be associated with increased importation of dogs into the UK, often involving dogs rescued from southern or eastern Europe (Norman et al. 2020, Traversa 2020)…

Item Type:	Journal Article
Murdoch Affiliation:	School of Veterinary and Life Sciences
Publisher:	Blackwell Publishing
Copyright:	© 2020 British Small Animal Veterinary Association
URI:	http://researchrepository.murdoch.edu.au/id/eprint/58525

Item Control Page